GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.

The FDA has introduced Elsa, an internal AI tool to review safety data, identify labeling issues, and prioritize inspections, ...

Children younger than 6 years of age who are prescribed extended-release stimulants for attention-deficit hyperactivity disorder (ADHD) may experience ...

The Food and Drug Administration (FDA) has approved an updated label for Amyvid (florbetapir F 18 injection) to support Alzheimer disease diagnosis in patients.

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

The FDA now requires ADHD extended-release drug labels to warn of weight loss risks in children under 6, urging monitoring ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

India’s top drug regulator is considering Braille labeling on medicine packaging to aid 4.95 million blind and 70 million visually impaired citizens and combat counterfeits.

Those who take the medicine should "urgently" check if they have batch number MD4L07 with an expiry date of 01/2028 as a precautionary measure, the agency says. The warning comes after the ...

Patients who take a common drug for high blood pressure are being urged to check the medication after its manufacturer reported that a mistake in the strength of the dose had been printed on some ...

The advice for those who have already been prescribed medication from this batch was to get in touch with their GP or pharmacist immediately. Those unable to do so should call NHS 111.

SAN DIEGO — Patients with alpha-gal syndrome need ingredient transparency to avoid animal-derived products in medications, according to a presentation here. The results of this process ...